Search Results - "Döring, Friederike"
-
1
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder
Published in Movement disorders (01-01-2018)“…ABSTRACT Background Increasing evidence connects the gut microbiota and the onset and/or phenotype of Parkinson's disease (PD). Differences in the abundances…”
Get full text
Journal Article -
2
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
Published in Movement disorders (01-01-2019)“…Objectives The objectives of this study were to investigate (1) the annual rate of progression of motor and cognitive symptoms and (2) baseline predictors of…”
Get full text
Journal Article -
3
Parkinson's disease sleep scale-validation of the revised version PDSS-2
Published in Movement disorders (01-03-2011)“…Background: The previous Parkinson's disease sleep scale (PDSS) is a 15‐item visual analogue scale that assesses the profile of nocturnal disturbances in…”
Get full text
Journal Article -
4
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease
Published in Movement disorders (01-01-2023)“…ABSTRACT Background Recent studies point toward a significant impact of cardiovascular processes and inflammation on Parkinson's disease (PD) progression…”
Get full text
Journal Article -
5
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
Published in Brain (London, England : 1878) (18-04-2022)“…Several studies have confirmed the α-synuclein real-time quaking-induced conversion (RT-QuIC) assay to have high sensitivity and specificity for Parkinson's…”
Get full text
Journal Article -
6
Accurate Detection of α‐Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort
Published in Movement disorders (01-04-2023)“…ABSTRACT Background Misfolded α‐synuclein (αSyn) aggregates (αSyn‐seeds) in cerebrospinal fluid (CSF) are biomarkers for synucleinopathies such as Parkinson's…”
Get full text
Journal Article -
7
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Published in Lancet neurology (01-03-2011)“…Summary Background Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy are brain disorders characterised by intracellular α-synuclein…”
Get full text
Journal Article -
8
Video-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study Group
Published in Sleep (New York, N.Y.) (14-03-2022)“…Abstract Video-polysomnography (v-PSG) is essential for diagnosing rapid eye movement (REM) sleep behavior disorder (RBD). Although there are current American…”
Get full text
Journal Article -
9
Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort
Published in Neurology (01-10-2013)“…OBJECTIVE:To determine nonmotor signs (NMS) and evaluate the utility of several diagnostic tools in patients with de novo Parkinson disease (PD). METHODS:This…”
Get full text
Journal Article -
10
The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease
Published in Movement disorders clinical practice (Hoboken, N.J.) (01-03-2018)“…Background Rapid eye movement (REM) sleep behavior disorder (RBD) is one of the most specific prodromal indicators for Parkinson's disease (PD). Objectives To…”
Get full text
Journal Article -
11
Arousal characteristics in patients with Parkinson’s disease and isolated rapid eye movement sleep behavior disorder
Published in Sleep (New York, N.Y.) (01-12-2021)“…Abstract Study Objectives Patients diagnosed with isolated rapid eye movement (REM) sleep behavior disorder (iRBD) and Parkinson’s disease (PD) have altered…”
Get full text
Journal Article -
12
A data-driven system to identify REM sleep behavior disorder and to predict its progression from the prodromal stage in Parkinson's disease
Published in Sleep medicine (01-01-2021)“…To investigate electroencephalographic (EEG), electrooculographic (EOG) and micro-sleep abnormalities associated with rapid eye movement (REM) sleep behavior…”
Get full text
Journal Article -
13
The role of intraoperative microelectrode recording and stimulation in subthalamic lead placement for Parkinson's disease
Published in PloS one (06-11-2020)“…Intraoperative microelectrode recording (MER) and test-stimulation are regarded as the gold standard for proper placement of subthalamic (STN) deep brain…”
Get full text
Journal Article -
14
Diagnostic value of the REM sleep behavior disorder screening questionnaire in Parkinson's disease
Published in Sleep medicine (01-01-2015)“…Highlights • Validation of the RBD screening questionnaire (RBDSQ) in 2 patient samples with Parkinson's disease. • The diagnostic value of the RBDSQ differed…”
Get full text
Journal Article -
15
Monitoring of 30 marker candidates in early Parkinson disease as progression markers
Published in Neurology (12-07-2016)“…OBJECTIVE:This was a longitudinal single-center cohort study to comprehensively explore multimodal progression markers for Parkinson disease (PD) in patients…”
Get full text
Journal Article -
16
Clinically relevant cut-off values for the parkinson's disease sleep scale-2 (PDSS-2): a validation study
Published in Sleep medicine (01-08-2016)“…Highlights for Ms: Clinically Relevant Cut-Off Values for the Parkinson's Disease Sleep Scale-2 (PDSS-2): a Validation Study • Nocturnal disturbances are an…”
Get full text
Journal Article -
17
REM sleep-associated motor behaviors in Parkinson's disease patients with heterozygous Parkin mutations
Published in Movement disorders (01-04-2015)Get full text
Journal Article -
18
Need for a consensus on definitions and on research methods in RBD and its prodromal phases
Published in Sleep (New York, N.Y.) (01-05-2019)Get full text
Journal Article -
19
-
20
Minocycline 1-year therapy in multiple-system-atrophy: Effect on clinical symptoms and [11C] (R)-PK11195 PET (MEMSA-trial)
Published in Movement disorders (15-01-2010)“…The aim of the study was to investigate the efficacy of the antibiotic minocycline as a drug treatment in patients with Multiple‐System‐Atrophy Parkinson‐type…”
Get full text
Journal Article